New ControlMap Free and Essentials tiers remove the cost and complexity barriers to delivering compliance as a core service, making it easier to start every client on a path to stronger risk management, trust, and long-term growth.
Read More
A fellowship-trained foot and ankle surgeon with expertise in reconstruction, sports injuries, and limb salvage, Dr. Talisse brings advanced care to three South Metro Atlanta locations.
Read MoreAcquisition Enhances Premier Resort Network Across the Caribbean and Mexico, Automates Group Travel, and Positions Platform for Accelerated Ramp Through NextTrip Integration
Read More
Positions IGC at the intersection of biotech innovation and cannabinoid science in one of the largest unmet medical needs in the world
Alzheimer's affects over 50 million people globally, with more than 400 million at risk from underlying disease pathology
Click here to register
Company plans to file its Earnings Report on August 14, 2025 on Form 10-Q for the quarter ended June 30, 2025
Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register
Read More
ReRaiseIt Launches a Transparent, Community-Driven Platform That Combines Fundraising With Sustainable Resale, Empowering Individuals and Organizations to Turn Unused Items Into Real-World Impact Through Commerce-Integrated Giving
Read MoreManuscript accepted for publication in Frontiers in Pharmacology, "Oral Administration of Ketamir-2, a Novel Ketamine Analog, Attenuates Neuropathic Pain in Rodent Models via Selective NMDA Antagonism" details Ketamir-2's superior performance in two validated neuropathic pain models and supports advancement to Phase 2a clinical trials by year-end 2025.
Read MoreOperational Efficiencies Improve, Increasing EBITDA and Cash Flow
Revenue increased 3% to $5.6M compared to $5.5M in Q1 2025 and decreased 7% from $6.0M in Q2 2024
Adjusted EBITDA increased $308,000 to $836,000 compared to $528,000 in Q2 2024
The Company was cash flow positive for the quarter, with cash flow from operations increasing $325,000 from Q2 2024
Subscriptions increased to 971 at the end of Q2 2025 from 955 at the end of Q1 2025 and 867 in Q2 2024
Record Quarterly Revenue of $6.3 Million in Q2; a 6-fold Increase YoY and 50% Growth QoQ
Ended Second Quarter with $68.6 Million of Cash to Support Growth Plan
$22.0 million backlog at end of Q2 2025
Expected New Orders Across Europe, the Middle East and the United States in 2H 2025 Position OAS for Accelerated Global Expansion into 2026
Conference Call Scheduled for Today at 8:30 a.m. ET
Read More